Status:
COMPLETED
Retrieval-Based Word Learning in Developmental Language Disorder
Lead Sponsor:
Purdue University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Developmental Language Disorder
Specific Language Impairment
Eligibility:
All Genders
48-71 years
Phase:
NA
Brief Summary
Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the child...
Detailed Description
Although much of the DLD literature has emphasized morphosyntax, those children with morphosyntactic weaknesses also have major deficits in vocabulary (McGregor et al., 2012), and sophisticated statis...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- a significant deficit in language ability (language test score below cutoff for best sensitivity/specificity) or documented age-appropriate language ability.
- normal hearing
- no evidence of neurological damage or disease
- scores on tests of nonverbal intelligence above the intellectual disability range
- not within Autistic range on Autism screening test
- native English speaker (can be bilingual)
- Exclusion Criteria
- failed hearing screening
- known neurological damage or disease
- scores on tests of nonverbal intelligence below the intellectual disability range (standard score less than 75)
- autism spectrum disorder
- non-native English speaker
Exclusion
Key Trial Info
Start Date :
March 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05325333
Start Date
March 16 2022
End Date
February 12 2024
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purdue University
West Lafayette, Indiana, United States, 47907